Catheter Precision, Inc. (VTAK) Form 10-Q — May 18, 2026
Catheter Precision, Inc. (VTAK) reported a net loss of $1.7 million for the three months ended March 31, 2026, with total revenue of $432,000, driven by the addition of its newly acquired private aviation segment. The company completed the acquisition of Fly Flyte, Inc. (FLYTE) for approximately $14.8 million, creating two reportable segments: cardiac electrophysiology and private aviation.
Key figures
- Revenue
- 432000
- Total Debt
- 3214000
- Revenue Yoy
- 202%
- Cash Position
- 441000
- Deal Value Usd
- 14753000
- Gross Proceeds
- 2200000
- Offering Price
- 1.43
- Shares Offered
- 392608
- Goodwill
- 9725000
- Reverse split ratio
- 1:19
- Deferred consideration
- 8151000
- Flyte acquisition value
- 14753000
Price after filing
1 day: -0.8%7 days: -4.3%30 days: +18.1%
Close on the filing date to close N calendar days later (from $0.83). Historical, not a forecast.
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.